Advertisement

Insulintherapie

  • Peter Hürter
Chapter

Zusammenfassung

Eine Diskussion über Indikationen zur Insulintherapie gibt es in der pädiatrischen Diabetologie nicht, denn jedes diabetische Kind und jeder diabetische Jugendliche müssen lebenslang mit Insulin behandelt werden. Diese folgenschwere Tatsache muß, so bitter sie ist, allen Eltern sofort nach Manifestation des Diabetes in schonender, aber eindeutiger Weise dargelegt werden.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. American Diabetes Association (1988) Position statement on jet injectors. Diabetes Care 11:600Google Scholar
  2. Ammon HPT, Schatz H (1995) Verlautbarung der Deutschen Diabetes-Gesellschaft zur subkutanen Insulinapplikation. Diab Stoffw 4: 382Google Scholar
  3. Berson SA, Yalow RS (1959) Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest 39: 1996Google Scholar
  4. Bertram F (1953) Klinische Beobachtungen über neue verzögernd wirkende Insulinpräparate. Verh Dtsch Ges Inn Med 59:242Google Scholar
  5. Brange J, Owens DR, Kang S, Solund A (1990) Monomeric insulins and their experimental and clinical implications. Diabetes Care 13: 923–954Google Scholar
  6. Field JB (1973) Extraction of insulin by liver. Am Rev Med 24: 309CrossRefGoogle Scholar
  7. Frank BH, Chance RE (1983) Two routes for producing human insulin utilizing recombinant DNA technology. Munch Med Wochenschr 125 (Supp 1)x4Google Scholar
  8. Goeddel DV, Kleid DG, Bolivar F et al. (1979) Expression in escherichia coli of chemically synthesized genes for human insulin. Proc Natl Acad Sci (Wash) 76: 106CrossRefGoogle Scholar
  9. Hagedorn HC, Jensen NB, Krarup NB, Wodstrup J (1936) Protamine insulinate. Acta Med Scand (Suppl) 78: 678Google Scholar
  10. Hallas-Moller K, Petersen K, Schlichtkrull J (1951) Crystalline and amorphous insulin-zinc compounds with prolonged action. Ugeskr Laeger 113: 1761PubMedGoogle Scholar
  11. Houtzargers CMGJ, Berntzen PA, Stap H van der, Heine RJ,Veen EA van der (1988) Absorption kinetics of short-and intermediate-acting insulin after jet injection with Medi-Jector II. Diabetes Care 11739Google Scholar
  12. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR (1994) (Lys (B28), Pro (1329)-human insulin a rapidly absorbed analogue of human insulin. Diabetes 43: 396–400Google Scholar
  13. Johnson IS (1983) Human insulin from recombinant DNA technology. Science 219: 632PubMedCrossRefGoogle Scholar
  14. Krayenbühl C, Rosenberg T (1946) Crystalline protamine-insulin. Rep Steno Mem Hosp (Kbh) 1:60Google Scholar
  15. Markussen J (1982) Process for preparing esters of human insulin. US patent 5 343898Google Scholar
  16. Obermeier R, Geiger R (1976) A new semisynthesis of human insulin. Hoppe Seylers Z Physiol Chem 357: 759PubMedCrossRefGoogle Scholar
  17. Scott DA, Fisher AM (1935) The effect of zinc salts on the action of insulin. J Pharmacol Exp Ther 55: 206Google Scholar
  18. Starke AAR, Heinemann L, Hohmann A, Berger M (1989) The action profiles of human insulin preparations. Diabetic Med 6: 239PubMedCrossRefGoogle Scholar
  19. Thim L, Hansen MZ, Norris K et al. (1986) Secretion and processing of insulin precursors in yeast. Proc Natl Acad Sci USA 83: 6766PubMedCrossRefGoogle Scholar
  20. Vorstand der Deutschen Diabetes-Gesellschaft (1994) Standardisierung der Insulinkonzentration auf loo E/ml am 1.6.1997 in Deutschland, Frankreich and Italien. Diab Stoffw 3:445–446Google Scholar
  21. Waldhäusl WK, Gasic S, Bratusch-Marrain P, Nowotny P (1983) The 75-g oral glucose tolerance test: effect on splanchnic metabolism of substrates and pancreatic hormone release in healthy man. Diabetologia 25: 489PubMedCrossRefGoogle Scholar
  22. Waldhäusl W, Bratusch-Marrain P, Kruse V, Jensen J, Nowotny P, Vierhapper H (1985) Effect of insulin antibodies on insulin pharmacokinetics and glucose utilization in insulin-dependent diabetic patients. Diabetes 34: 166PubMedCrossRefGoogle Scholar
  23. Woodworth J, Howey D, Bowsher R, Lutz S, Santa P, Brady P (1993) (Lys (B28), Pro (B29)) human insulin (K): dose ranging vs. Humulin R (H). Diabetes 42 (Suppl 1 ) 54AGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • Peter Hürter
    • 1
  1. 1.HannoverDeutschland

Personalised recommendations